See here an analysis of the similar UK protocol: http://covexit.com/oxford-recovery-evaluation-of-covid-19-therapy-flawed-against-hydroxychloroquine-and-dangerous-to-patients/ See Media Release: A European clinical trial to evaluate four experimental treatments for COVID-19 starts today.
Join Our Discussion Group
Une réduction d’au moins 50% de la mortalité due au COVID-19 est très probablement réalisable dans les résidences pour personnes âgées, par la prophylaxie et les traitements précoces, notamment à base d’Ivermectine. (lien vers l'article résumé) http://covexit.com/opinion-il-faut-soigner-tot-les-aines-malades-du-covid-19-et-non-les-laisser-mourir/
Outbreaks are on the increase in nursing homes. What is totally missing in all the measures taken so far is prophylaxis and early treatment of the elderly sick with COVID-19. Such therapies could likely halve the lethality rates in nursing homes. http://covexit.com/towards-another-bloodshed-in-canadas-elderly-homes/
- Professor Thomas Borody Interview – Part 1 This is the first part of our interview with the esteemed Professor Thomas Boro...
- Professor Christian Perronne Interview – Part 2 In this second part of our interview with Professor Christian Perronne, MD, PhD...
- Facebook Takes Down our Group! Today, Facebook took down the discussion group of COVEXIT, which had nearly 4,0...
- Professor Thomas Borody Interview – Part 2 In the second part of our interview with the esteemed Professor Thomas Borody f...
- One must treat early aged people with COVID-19 and not just let them die In the beginning of this fall season, everything points at an increasing number...
Other Noteworthy Articles
- The Professor Raoult Interview that Will Make the History BooksHere is a translation of the interview published today by Professor Didier Raoult, which covers not […]
- When It’s Too Late, It’s Too LateIn this video, Professor Didier Raoult comments on the progress so far with his treatment, provided […]
- Healthcare Workers Protected by HCQ Prophylaxis – StudyThe study “Pre-exposure Hydroxychloroquine use is associated with reduced COVID19 risk in […]
- COVID-19: Canadian Research Opts for Self-Screening, Self-Reporting, Suboptimal Medication and Placebos by Overnight Courrier!The title may seem exaggerated. Yet, it’s based on reality. Canadian research, has opted for […]
- Yale Epidemiology Professor Urges Hydroxychloroquine & Azithromycin Early Therapy for COVID-19“Available evidence of efficacy of HCQ+AZ has been repeatedly described in the media as […]